Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
4.690
+0.320 (7.32%)
Nov 22, 2024, 4:00 PM EST - Market closed
Adaptive Biotechnologies Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$6.50
Upside
+38.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +49.25% | Nov 11, 2024 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +70.58% | Oct 2, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +27.93% | Aug 2, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +6.61% | May 8, 2024 |
| BTIG | BTIG | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +6.61% | Apr 4, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $11 → $5 | Hold | Maintains | $11 → $5 | +6.61% | Feb 16, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $11 → $8 | Buy | Maintains | $11 → $8 | +70.58% | Feb 15, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $6 | Buy | Maintains | $13 → $6 | +27.93% | Nov 13, 2023 |
| JP Morgan | JP Morgan | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | +134.54% | Nov 10, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $13 → $10 | Hold | Maintains | $13 → $10 | +113.22% | Oct 24, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +177.19% | Oct 16, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +198.51% | Aug 8, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $14 → $13 | Hold | Maintains | $14 → $13 | +177.19% | Aug 4, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $14 | Hold | Maintains | $15 → $14 | +198.51% | May 5, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +219.83% | Feb 16, 2023 |
| Credit Suisse | Credit Suisse | Sell Reiterates $7 | Sell | Reiterates | $7 | +49.25% | Feb 15, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.